Ezetimibe and low density lipoprotein subfractions: An ongoing debate

Current Medical Research and Opinion

Volumn 27, Issue 3, 2011, Pages 693-695

  Katsiki, Niki ^a   Athyros, Vasilis G ^b   Karagiannis, Asterios ^b   Mikhailidis, Dimitri P ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Cholesterol; Ezetimibe; Simvastatin Small dense low density lipoprotein

Indexed keywords

C REACTIVE PROTEIN; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

BIOEQUIVALENCE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMBINATION CHEMOTHERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; MONOTHERAPY; REVIEW; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHEMICAL FRACTIONATION; CHOLESTEROL; CHOLESTEROL, LDL; DISSENT AND DISPUTES; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, LDL; PARTICLE SIZE; PROGNOSIS; SIMVASTATIN;

EID: 79951622207     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.554809     Document Type: Review

References (17)

1. Florentin M, Liberopoulos EN, Moutzouri E, et al. The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia. Curr Med Res Opin 2011;27:685-92
2. Berneis K, Rizzo M, Berthold HK, et al. Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial. Eur Heart J 2010;31:1633-9
3. Kalogirou M, Tsimihodimos V, Gazi I, et al. Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipi-daemia. Curr Med Res Opin 2007;23:1169-76 (Pubitemid 46799601)
4. Tomassini JE, Mazzone T, Goldberg RB, et al. Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia. Diabetes Obes Metab 2009;11:855-64
5. Gazi IF, Tsimihodimos V, Tselepis AD, et al. Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles. Expert Opin Biol Ther 2007;7:53-72 (Pubitemid 46091576)
6. Lioudaki E, Ganotakis ES, Mikhailidis DP. Ezetimibe; more than a low density lipoprotein cholesterol lowering drug? An update after 4 years. Curr Vasc Pharmacol 2011;9:62-86
7. Gazi IF, Daskalopoulou SS, Nair DR, et al. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin. Curr Med Res Opin 2007;23:2183-92 (Pubitemid 350246604)
8. Fras Z, Mikhailidis DP. Statin plus ezetimibe treatment in clinical practice: the SI-SPECT (Slovenia (SI) Statin Plus Ezetimibe in Cholesterol Treatment) monitoring of clinical practice study. Curr Med Res Opin 2008;24:2467-76
9. Migdalis I, Efthimiadis A, Pappas S, et al. Clinical experience with ezetimibe/simvastatin in a Mediterranean population. Curr Med Res Opin 2009; 25:2571-6
10. Florentin M, Tselepis AD, Elisaf MS, et al. Effect of non-statin lipid lowering and anti-obesity drugs on LDL subfractions in patients with mixed dyslipidae-mia. Curr Vasc Pharmacol 2010;8:820-30
11. Mikhailidis DP, Sibbring GC, Ballantyne CM, et al. Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Curr Med Res Opin 2007;23:2009-26 (Pubitemid 47300401)
12. Breimer LH, Mikhailidis DP. Primary prevention using statins: to be or not to be? Curr Med Res Opin 2010;26:2701-6
13. Holme I, Boman K, Brudi P, et al. Observed and predicted reduction of ische-mic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial. Am J Cardiol 2010;105:1802-8
14. Gerdts E, Rossebø AB, Pedersen TR, et al. Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study). Am J Cardiol 2010;106:1634-9
15. Available at http://www.ox.ac.uk/media/news-stories/2010/101122- 1.html [Last accessed 7 January 2011]
16. Rizzo M, Rini GB, Spinas GA, et al. The effects of ezetimibe on LDL-cholesterol: quantitative or qualitative changes? Atherosclerosis 2009; 204:330-3
17. Sarigianni M, Katsiki N, Mikhailidis DP. Ezetimibe in diabetes: more than cholesterol lowering? Curr Med Res Opin 2010;26:25